Worldwide biopharma M&A transaction volume by location 2015-2019
During 2019, the upfront transaction volume for mergers and acquisitions (M&A) in the global biopharma industry was the highest, totaling 253.9 billion U.S. dollars. Of that amount, U.S companies sold accounted for 148.7 billion U.S. dollars. This statistic depicts the global biopharma industry's mergers and acquisitions transaction volumes for 2015 to 2019, by location of sold companies, assets, or divisions.
